Novo Nordisk Ends Hims & Hers Partnership
This is a news story, published by Homepage, that relates primarily to Novo Nordisk news.
Novo Nordisk news
For more Novo Nordisk news, you can click here:
more Novo Nordisk newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsHomepage news
For more news from Homepage, you can click here:
more news from HomepageAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Novo Nordisk. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest FDA ruling news, FDA news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
WegovyHomepage
•Health
Health
Novo Nordisk accuses telehealth company Hims of 'deceptive marketing' and ends Wegovy partnership

72% Informative
Hims & Hers Health was accused of deceptively marketing weight-loss drugs.
Novo Nordisk said it took issue with the company’s continued sale of compounded versions of Wegovy .
Heirs & Hers had been offering one-month doses of compounded GLP-1 medications starting at $ 165 per month.
VR Score
69
Informative language
67
Neutral language
36
Article tone
formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links